eLaws | eCases | United States Code | Federal Courts |
Home » Rulemaking » Clay Hurtubise - Comment

Clay Hurtubise - Comment

Document ID: FDA-2010-N-0486-0002
Document Type: Public Submission
Agency: Food And Drug Administration
Received Date: October 06 2010, at 12:00 AM Eastern Daylight Time
Date Posted: October 27 2010, at 12:00 AM Eastern Standard Time
Comment Start Date: September 22 2010, at 12:00 AM Eastern Standard Time
Comment Due Date: January 31 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80b68d37
View Document:  View as format xml

View Comment

See attached file(s) As a Clinical Drug Trial Coordinator I see a lot of room for improvement in the field of investigational drug handling and administration. Some of the packaging from sponsors is simply alarming, and a sentinel (death) event is not if but when. The attached document is meant to open dialogue and try to improve patient safety.

Attachments:

Clay Hurtubise - Comment

Title:
Clay Hurtubise - Comment

View Attachment: View as format msw8

Related Comments

    View All
Total: 10
Clay Hurtubise - Comment
Public Submission    Posted: 10/27/2010     ID: FDA-2010-N-0486-0002

Jan 31,2011 11:59 PM ET
Joanne Locke - Comment
Public Submission    Posted: 10/27/2010     ID: FDA-2010-N-0486-0004

Jan 31,2011 11:59 PM ET
Pinney Associates - Comment
Public Submission    Posted: 10/27/2010     ID: FDA-2010-N-0486-0005

Jan 31,2011 11:59 PM ET
Safe Injection Practices Policy Task Force - Comment
Public Submission    Posted: 11/10/2010     ID: FDA-2010-N-0486-0006

Jan 31,2011 11:59 PM ET
Becton Dickinson (BD) - Comment
Public Submission    Posted: 11/10/2010     ID: FDA-2010-N-0486-0007

Jan 31,2011 11:59 PM ET